Application
Figure 1: Western blot analysis using SRA mouse mAb against truncated SRA recombinant protein (1) and human ovary cancer tissue lysate (2).Application
Figure 2: Immunohistochemical analysis of paraffin-embedded human bladder carcinoma (left) and breast carcinoma (right), showing nuclear and cytoplasmic localization using SRA mouse mAb with DAB staining.| Product Name | SRA |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | SRAP; STRAA1 |
| Immunogen | Purified recombinant fragment of SRA expressed in E. Coli. |
| Clonality | Monoclonal |
|---|---|
| Host Species | Unknow |
| Tested Applications | WBIHCICC/IF |
| WB:1:250~1:1000 IHC:1:20~1:100 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|
| Species Reactivity | Human |
| Alternative Names | SRAP STRAA1 |
|---|---|
| Molecular Weight(MW) | N/A |
| Entrez Gene | 10011 |
|---|
Application
Figure 1: Western blot analysis using SRA mouse mAb against truncated SRA recombinant protein (1) and human ovary cancer tissue lysate (2).
Application
Figure 2: Immunohistochemical analysis of paraffin-embedded human bladder carcinoma (left) and breast carcinoma (right), showing nuclear and cytoplasmic localization using SRA mouse mAb with DAB staining.| Application Notes | WB:1:250~1:1000 IHC:1:20~1:100 ICC/IF:1:100~1:200 Notes:Optimal dilutions/concentrations should be determined by the researcher. |
|---|
| Form | Ascitic fluid containing 0.03% sodium azide. |
|---|---|
| Storage Instructions | 4℃; -20℃ for long term storage |
